Related by context. All words. (Click for frequent words.) 84 ThermoDox R 79 ThermoDox 68 Proxinium TM 68 Archexin 67 sorafenib tablets 67 Nexavar ® 67 Azedra 67 EOquin TM 67 Allovectin 7 67 FOLOTYN ® 66 Amrubicin 66 Hsp# Inhibitor 66 Ceflatonin 66 relapsed multiple myeloma 66 YONDELIS 66 ARIKACE 65 HuMax EGFr 65 BrachySil TM 65 phase IIb clinical 65 Phase #b/#a clinical 65 oral ridaforolimus 65 non resectable 65 Pirfenidone 65 forodesine 65 Diabetic Macular Edema DME 65 Traficet EN 65 Phase 1b trial 65 DDP# 64 histone deacetylase HDAC inhibitor 64 paclitaxel poliglumex 64 ELACYT 64 ospemifene 64 oral deforolimus 64 Myocet 64 docetaxel Taxotere ® 64 docetaxel Taxotere R 64 methylnaltrexone bromide 64 MGd 64 tanespimycin 64 sorafenib Nexavar 64 metastatic hormone refractory 64 Diabetic Macular Edema 64 Chemophase 64 phase IIa clinical 64 pseudobulbar affect PBA 64 Zenvia ™ 64 SNT MC# 64 PrevOnco 64 Recurrent Chest Wall 64 relapsed refractory multiple myeloma 64 SUTENT ® 64 phase IIb trial 64 Ixempra 64 OHR/AVR# 64 oropharyngeal candidiasis 64 refractory chronic lymphocytic 64 bortezomib Velcade R 64 Amplimexon 64 HuMax CD4 64 FOLFOX6 chemotherapy regimen 63 CEQ# 63 SIR Spheres 63 IL# PE#QQR 63 vascular disrupting agent 63 Æterna Zentaris 63 Tanespimycin 63 acetonide FA 63 Bezielle 63 Nimotuzumab 63 PROMACTA 63 Alpharadin 63 Zerenex 63 ZEVALIN ® 63 AVASTIN 63 BCG refractory carcinoma 63 erlotinib Tarceva ® 63 novel oral anticoagulant 63 JAK inhibitor 63 anticancer compound 63 alvespimycin 63 targeted radiotherapeutic 63 PHX# 63 Iluvien ® 63 Genasense ® 63 Annamycin 63 OncoGel 63 oral prodrug 63 Tamibarotene 63 Phase III ThermoDox 63 cell lymphoma CTCL 63 Cellegesic 63 CRMD# 63 Apaziquone 63 rilonacept 63 Ventavis 63 IMA# 63 farletuzumab 63 ozarelix 63 HCV protease inhibitor 63 Clevudine 63 DOXIL 63 Phase III Clinical Trial 63 AEG# 63 monoclonal antibody conjugated 63 YONDELIS R 63 Tavocept 63 ILUVIEN ® 63 Panzem R 63 ZOLINZA 63 ixabepilone 63 luliconazole 63 TG# [003] 62 trabectedin 62 RhuDex ® 62 evaluating tivozanib 62 Toraymyxin TM 62 FOLOTYN 62 Investigational Treatment 62 Irinotecan 62 radiation sensitizer 62 REOLYSIN ® 62 Gemzar ® 62 Fibrillex TM 62 ularitide 62 Phase Ib study 62 dextromethorphan quinidine 62 PKC# 62 bevacizumab Avastin ® 62 advanced hepatocellular carcinoma 62 Mitoxantrone 62 Restanza 62 CoFactor 62 rNAPc2 62 standard chemotherapy regimen 62 Lubiprostone 62 OMNARIS HFA 62 Evoltra 62 octreotide implant 62 Catena ® 62 methylnaltrexone 62 RCW breast cancer 62 lucinactant 62 KRN# 62 Pafuramidine 62 pertuzumab 62 PrevOnco ™ 62 Phase IIb clinical trials 62 MAGE A3 ASCI 62 Zenvia Phase III 62 Glufosfamide 62 mapatumumab 62 Gemcitabine 62 Ceflatonin R 62 induced macular edema 62 sunitinib malate 62 opioid induced constipation OIC 62 Elagolix 62 Aflibercept 62 Vicinium TM 62 EOquin 62 HGS# 62 IRX 2 62 ACTEMRA TM 62 Bazedoxifene 62 Fast Track Designation 62 neratinib 62 Allovectin 7 ® 62 Onalta 62 registrational 62 Icatibant 62 CA4P 62 AZILECT ® 62 CIMZIA TM 62 reslizumab 62 TEMODAL 62 Urocidin 62 eniluracil 62 diabetic neuropathic pain 62 liposomal doxorubicin 62 Troxatyl 62 AP# [003] 62 Dapagliflozin 62 Hsp# inhibitor 62 mertansine 62 molecular imaging radiopharmaceutical 62 Celsion Corporation 62 Squalamine 62 elotuzumab 62 pivotal Phase III 62 mitogen activated ERK kinase 62 Raptiva ® 62 Friedreich Ataxia FRDA 62 SUCCEED trial 62 non metastatic osteosarcoma 62 relapsing multiple sclerosis 62 FUSILEV ® 62 IIa trial 62 Phenoptin 62 denileukin diftitox 62 gemcitabine chemotherapy 62 LibiGel ® 62 refractory AML 62 thetreatment 62 romidepsin 62 Ceflatonin ® 61 vapreotide acetate 61 bevacizumab Avastin 61 Actemra tocilizumab 61 ruxolitinib 61 Meets Primary Endpoint 61 Orphan Drug status 61 registrational trial 61 axitinib 61 EFAPROXYN 61 randomized Phase IIb 61 Abiraterone acetate 61 amrubicin 61 TORISEL 61 Granted Orphan Drug 61 Dabigatran etexilate 61 Telatinib 61 Evoltra ® 61 Asentar 61 DAVANAT 61 oral antiviral 61 Aloxi R 61 Panzem R NCD 61 trastuzumab Herceptin R 61 Epratuzumab 61 Aliskiren 61 metastatic pancreatic 61 Trobalt 61 opioid induced bowel dysfunction 61 Anturol TM 61 Fludara ® 61 Aplidin 61 Cloretazine 61 Sanvar R 61 BRIM2 61 oral Xeloda 61 Phase IIa trials 61 ADVEXIN 61 NP2 Enkephalin 61 Safinamide 61 LHRH antagonist 61 Metastatic Melanoma 61 Hepatocellular Carcinoma HCC 61 TNF Tumor Necrosis Factor 61 Phase 2b clinical 61 ATL# [001] 61 liposomal formulation 61 INCB# [001] 61 aflibercept 61 fosbretabulin 61 Teysuno 61 BrachySil 61 lymphoma CTCL 61 huC# DM4 61 pain palliation 61 OMAPRO ™ 61 VIVITROL ® 61 esophageal candidiasis 61 Clolar ® 61 Onrigin 61 Vandetanib 61 Celsion 61 Prospective Randomized 61 unique alkylating agent 61 REVLIMID lenalidomide 61 vidofludimus 61 Aztreonam 61 BRAF inhibitor 61 Pazopanib 61 bendamustine HCl 61 PNP inhibitor 61 OncoVEX GM CSF 61 GATTEX TM 61 R sorafenib tablets 61 deforolimus 61 aerosolized AAT 61 Xanafide 61 WX UK1 61 TASQ 61 VEGF Trap 61 CYT# potent vascular disrupting 61 Phase Ib 61 Tolvaptan 61 Durezol TM 61 Microplasmin 61 Octreolin 61 BrachySil ™ 61 Perifosine 61 recurrent NSCLC 61 gastrointestinal stromal tumors GIST 61 Personalized Immunotherapy 61 Oracea TM 61 noninfectious uveitis 61 MOZOBIL 61 Yondelis ® 61 TRO# 61 REVLIMID R 61 cancer neuroendocrine tumor 61 Vidaza azacitidine 61 Bicifadine 61 oxypurinol 61 Zarnestra 61 Insegia 61 recurrent glioblastoma multiforme 61 Zingo TM 61 Manja Bouman CEO 61 FASLODEX 61 PSN# [001] 61 multi kinase inhibitor 61 dasatinib Sprycel ® 61 CAELYX 61 HER2 positive metastatic breast 61 unresectable liver cancer 61 JAK2 Inhibitor 61 Methylnaltrexone 61 afamelanotide 61 Cimzia TM 61 Cetrorelix 61 Initiate Clinical Trial 61 Oxaliplatin 61 immunotherapeutic vaccine 61 Tracleer r 61 refractory acute myeloid 61 investigational monoclonal antibody 61 Besivance 61 phase IIb 61 SUTENT 61 infusional 5-FU/LV 61 Sapacitabine 61 Imprime PGG 61 BEMA TM Fentanyl 61 Pyridorin 61 MT# MEDI 61 OPAXIO 61 vorinostat 60 oral anticoagulant 60 iSONEP 60 Oral Mucositis 60 superficial bladder cancer 60 Tracleer R 60 metastatic castrate resistant 60 OZURDEX ® 60 TREANDA 60 CINTREDEKIN BESUDOTOX 60 thrombolytic agent 60 biliary tract cancer 60 Sym# 60 Soliris TM eculizumab 60 herpetic keratitis 60 Solasia 60 bortezomib Velcade ® 60 Marketing Authorisation Application 60 advanced carcinoid 60 LymphoStat B TM 60 ProLindac TM 60 LHRH antagonists 60 dose escalation trial 60 BioNumerik 60 ketolide antibiotic 60 Xeloda ® 60 Civacir 60 subcutaneous formulation 60 proteasome inhibitor bortezomib 60 ZACTIMA 60 XIAFLEX ® 60 oxymorphone ER 60 TRISENOX 60 Quinamed 60 dirucotide MBP# 60 R bortezomib 60 BARACLUDE R 60 Exelixis compounds 60 Onrigin TM 60 temsirolimus Torisel ® 60 Phase 2b study 60 CytoFab 60 Evoltra TM 60 SYCREST 60 RAPAFLO 60 orphan designation 60 liver resection surgeries 60 metaglidasen 60 pexiganan 60 EpiCeram 60 Phase IIIb clinical 60 LEVADEX ™ 60 Golimumab 60 fipamezole 60 NEUMUNE 60 UPLYSO 60 TYKERB 60 RoACTEMRA 60 PXD# 60 R#/MEM # 60 bendamustine 60 Simulect 60 ponatinib 60 drug eluting stent DES 60 Zemplar Capsules 60 Phase Ib II 60 Helsinn Healthcare 60 Clavis Pharma 60 Elesclomol 60 phase Ib 60 Urocidin TM 60 PDX pralatrexate 60 VAPRISOL 60 PREOS 60 confirmatory Phase III 60 SANVAR 60 Myelodysplastic Syndrome MDS 60 sorafenib Nexavar ® 60 rasagiline tablets 60 ARIKACE ™ 60 Tarvacin TM 60 SUPPRELIN R LA 60 Pertuzumab 60 antiplatelet agent 60 HP Acthar Gel repository 60 Alinia 60 capecitabine Xeloda 60 lubiprostone 60 Phase III Trial 60 INC# 60 apaziquone 60 adult chronic ITP 60 Liprotamase 60 Cysteamine 60 Combination REOLYSIN R 60 DP b# 60 NVA# 60 pralatrexate 60 sulodexide 60 Gliadel Wafer 60 IV Busulfex 60 drug ISA# 60 Azixa 60 Dacogen injection 60 pioglitazone HCl 60 Tezampanel 60 HQK 60 Peginterferon alfa 2b 60 NAVISTAR R 60 Acute Ischemic Stroke 60 Cutaneous T 60 photodynamic therapy PDT 60 corticosteroid dexamethasone 60 BAY #-# 60 COMFORT II 60 DC Bead 60 generation purine nucleoside 60 metastatic castration resistant 60 Phase Ib clinical 60 MyVax R 60 ALN TTR 60 Ridaforolimus 60 Dyloject TM 60 clofarabine 60 Delcath PHP System 60 constipation OIC 60 Rituxan rituximab 60 Reolysin 60 Alzhemed TM 60 KNS # 60 Phase III pivotal 60 Daclizumab 60 Ofatumumab 60 VISICOL R 60 VALSTAR 60 luteinizing hormone releasing 60 Hycamtin 60 lexidronam injection 60 receptor tyrosine kinase inhibitor 60 EVIZON TM 60 Vaprisol 60 Lialda 60 CVac 60 Aurexis 60 entinostat 60 Efficacy Results 60 rhITF 60 Phase 2a clinical 60 Phase 2b Clinical Trial 60 Pivotal Trial 60 Bendamustine 60 Anthim 60 lumiliximab 60 Phase IIb Trial 60 ISTODAX ® 60 Ophena TM 60 Clinical Trial Results 60 Dupuytren Contracture 60 acyclovir Lauriad R 60 JAK2 inhibitor 60 Pemetrexed 60 virus HCV protease inhibitor 60 Fibrin Pad 60 Tyrima 60 AEGR 60 relapsed leukemia 60 LEUKINE 60 MEK inhibitor RDEA# 60 Fodosine 60 Taiho Pharmaceutical 60 RELISTOR ® 60 trial evaluating PRX# 60 Voraxaze ™ 60 Everolimus 60 Phase #b/#a 60 Blinatumomab 60 Advanced Renal Cell 60 Maribavir 60 Mipomersen 60 Xcytrin R 60 everolimus tablets 60 IMiDs ® 60 CCX# B 60 gemcitabine Gemzar ® 60 custirsen 60 Cotara 60 Herceptin trastuzumab 60 Taxotere ® 60 ADP receptor antagonist 60 Fortical R 60 Phase 2b 60 Mepact 59 Phase #/#a 59 nucleoside analog 59 vitreoretinal disorders 59 Increlex ® 59 chronic thromboembolic pulmonary 59 biologic therapy 59 tezampanel 59 ASONEP 59 Lucanix R 59 cetuximab Erbitux ® 59 Oracea ® 59 omacetaxine mepesuccinate 59 Wafer polifeprosan 59 Tectin TM 59 brivaracetam 59 indolent NHL 59 phase IIb study 59 pan HDAC inhibitor 59 interferon gamma 1b 59 metastatic colorectal 59 EcoNail 59 Azilect ® 59 MabCampath 59 investigational humanized monoclonal antibody 59 diabetic gastroparesis 59 talactoferrin 59 Zoraxel 59 Kepivance 59 eritoran 59 Carfilzomib 59 Degarelix 59 brand ciclesonide HFA 59 tamibarotene 59 Phase 2b clinical trials 59 Novolimus 59 Aryplase 59 INSPIRE Trial Phase III 59 relapsed ovarian cancer 59 ongoing Phase 1b 59 Deforolimus 59 Perforomist ™ Inhalation Solution 59 Opterone R 59 Afinitor ® 59 refractory CLL 59 systemic anaplastic large 59 Telavancin 59 catheter occlusion 59 Bayer Onyx 59 IGF 1R inhibitor 59 histone deacetylase inhibitor 59 Microspheres 59 depsipeptide 59 Dacetuzumab 59 Alocrest 59 commercialize deforolimus 59 candidate TNFerade biologic 59 Xeloda capecitabine 59 lomitapide 59 tivozanib 59 multiple myeloma MM 59 motexafin gadolinium Injection 59 Pivotal Phase III 59 GLASSIA 59 ONGLYZA ™ 59 Phase IIa clinical 59 cutaneous T cell 59 Soliris eculizumab 59 Phase 2a 59 Avastin bevacizumab 59 BENLYSTA ® 59 fallopian tube carcinoma 59 Nippon Kayaku 59 Orazol 59 PRT# 59 relapsing remitting MS RRMS 59 subsidiaries visit http:/www.apricusbio.com 59 Romidepsin 59 injectable formulation 59 HDAC Inhibitor 59 Zelrix 59 ganetespib 59 PF # [001] 59 refractory cutaneous T 59 ezogabine 59 OvaRex ® MAb 59 Phase 2b trial 59 BAL# [002] 59 angiotensin receptor blocker ARB 59 Troxatyl TM 59 IMiDs R 59 LIALDA 59 investigational drug 59 TAXOTERE R 59 Initiate Phase II 59 PEGylated interferon beta 1a 59 hepatocellular cancer 59 Tarceva TM 59 Trofex 59 Alvesco R 59 Luveniq 59 SPRYCEL ® 59 recurrent metastatic ovarian cancer 59 Nexavar sorafenib 59 refractory PTCL 59 ara C 59 plasma kallikrein inhibitor 59 Lixivaptan 59 dacetuzumab 59 PROCRIT R 59 selective androgen receptor modulator 59 AQ4N 59 Raptiva R 59 Fast Track Status 59 Taxotere R 59 Phase 1b clinical 59 TYGACIL 59 CCR9 antagonist 59 Ganite R 59 SinuNase 59 RSR# 59 omega interferon 59 TYZEKA 59 HGS ETR1 59 investigational immunotherapy 59 Virulizin ® 59 CINQUIL 59 metastatic renal cell carcinoma 59 mild vasodilator 59 ® bortezomib 59 Cloretazine R VNP#M 59 Panzem NCD 59 CIMZIA ™ 59 metastatic sarcomas 59 QuadraSphere 59 TELINTRA 59 Phase IIb clinical 59 TAXUS Element Paclitaxel Eluting 59 Efficacy Trial 59 invasive candidiasis 59 PANVAC VF 59 pediatric acute lymphoblastic 59 EndoTAG TM -1 59 BZL# 59 LIVALO 59 CTAP# Capsules 59 XL# anticancer compounds 59 Transdrug ® nanoparticle 59 doxorubicin Transdrug ® 59 Acute Radiation Syndrome ARS 59 Immunotherapeutic 59 post herpetic neuralgia PHN 59 thymalfasin 59 refractory APL 59 DexaSite 59 Guanilib 59 IPLEX 59 Ambrisentan 59 Removab 59 Tiuxetan 59 perifosine 59 ABILIFY R 59 albinterferon alfa 2b 59 vinca alkaloid 59 severe gastroparesis 59 Pixuvri 59 FDA APPROVES 59 compound INCB# 59 Brentuximab Vedotin SGN 59 Prestara 59 vosaroxin 59 ACAPODENE 59 mTOR inhibitor 59 AZILECT R 59 Genasense R 59 Receives Orphan Drug Designation 59 PEGylated anti 59 multicenter clinical 59 NDA Submission 59 II Clinical Trial 59 Intravenous CP 59 INCB# [002] 59 Panzem 59 Amigal 59 Denufosol 59 IRESSA 59 recurrent metastatic 59 Zerenex ™ 59 GATTEX ™ 59 Phase III clinical 59 MEND CABG II 59 arsenic trioxide injection 59 intravesical infusion therapy 59 Campath ® 59 volociximab 59 Firazyr 59 Phase #/#a trial 59 DepoDur 59 MEK Inhibitor 59 Treanda 59 iobenguane 59 Phase III 59 atrasentan 59 Acute Radiation Syndrome 59 SinuNase TM 59 XL# [003] 59 Mimpara 59 delivers fluocinolone acetonide FA 59 microsphere therapy 59 capecitabine Xeloda R 59 antibody MAb 59 cinacalcet 59 PI3K/Akt pathway inhibitor 59 metastatic malignant 59 Collategene 59 ibuprofen Injection 59 BCR ABL inhibitors 59 eprotirome 59 Initiates Phase II 59 Seliciclib 59 cinacalcet HCl 59 PEGINTRON TM 59 tiuxetan 59 Phase III HEAT 59 Bortezomib 59 leukemia AML 59 cutaneous T 59 TNFerade 59 palliative radiotherapy 59 oxybutynin gel 59 bortezomib Velcade 59 lorvotuzumab mertansine 59 Xcytrin 59 enzastaurin 59 Bevacizumab 59 orally administered inhibitor 59 Lenalidomide 59 Omigard TM 59 Cetuximab Erbitux 59 dirucotide 59 CBLC# 59 Cloretazine ® 59 Orphan Drug designations 59 Vitrasert R 59 ulimorelin 59 Phase 1b 59 Lacosamide 59 Doxorubicin 59 Gliadel R 59 Exherin TM 59 chronic idiopathic thrombocytopenic purpura 59 thalidomide Thalomid 59 AeroLEF TM 59 Talabostat 59 Intravenous Human 59 terlipressin 59 bazedoxifene 59 diabetic macular edema DME 59 Linaclotide 59 Jevtana 59 Allovectin 7 R 59 ADVEXIN p# therapy 59 Phase Ib clinical trials 59 chemotherapy induced neutropenia 59 CLORETAZINE TM VNP#M 58 Sanofi Aventis Taxotere 58 casopitant 58 Laquinimod 58 Preotact 58 chronic angina 58 PEG SN# 58 GTC recombinant human 58 tipranavir 58 IAP inhibitors 58 Onalta ™ 58 Mitomycin C 58 AzaSite Plus 58 PD LID 58 Carboplatin 58 Neuradiab 58 RLY# 58 AGGRASTAT ® 58 triphendiol 58 Orphan Medicinal Product 58 Solesta 58 Zemplar 58 angiogenesis inhibitor 58 Surfaxin LS 58 Clonicel 58 LUVENIQ 58 peritumoral brain edema 58 GALNS 58 phase IIa 58 OncoVex 58 PROCRIT 58 FIRAZYR 58 BYETTA ® 58 PRX# 58 selective orally bioavailable 58 BLP# Liposome Vaccine 58 Frova ® 58 Cancidas 58 oral salmon calcitonin 58 bicifadine 58 placebo controlled clinical 58 CR# vcMMAE 58 sodium Injection 58 placebo controlled Phase III 58 ORENCIA R 58 ENLIGHT 58 microwave hyperthermia 58 trastuzumab DM1 T DM1 58 Viprinex 58 severe oral mucositis 58 orphan medicinal product 58 humanized monoclonal antibody 58 TNFerade TM 58 Ganite ® 58 lintuzumab 58 riociguat 58 Darinaparsin 58 picoplatin 58 SCH # 58 Ventavis ® 58 Melphalan 58 RG# [001] 58 malignant ascites 58 Ophena 58 hormone LHRH antagonist 58 overactive bladder syndrome 58 Inhalation Aerosol 58 CLL8 58 histamine dihydrochloride 58 BEMA Fentanyl 58 Copegus ribavirin 58 SABCS 58 Voreloxin 58 Betaferon ® 58 Advanced Melanoma 58 Omigard 58 NGX# 58 Pixantrone 58 rALLy clinical trial 58 pegylated interferons 58 IPX# 58 sunitinib Sutent 58 Satraplatin 58 topical NSAID 58 RANK Ligand inhibitor 58 methotrexate MTX 58 AzaSite Xtra 58 trastuzumab DM1 58 obatoclax 58 PEGylated interferon 58 refractory prostate cancer 58 systemic fungal infections 58 PREOS R 58 FDA Approvable Letter 58 either acutely decompensated 58 MBP# [001] 58 candidate Zenvia 58 CAPHOSOL 58 Silodosin 58 Atiprimod 58 FDA Orphan Drug 58 Genasense oblimersen sodium Injection 58 2 methoxyestradiol 58 ARCALYST 58 personalized cellular immunotherapy 58 cetuximab Erbitux 58 ORENCIA ® 58 Dose Escalation 58 lenalidomide Revlimid R 58 investigational pharmacologically unique 58 PF # [002] 58 AeroLEF 58 Panitumumab 58 Eluting Coronary Stent System 58 alvimopan 58 Pradefovir 58 IMiDs ® compound 58 Taxotere docetaxel 58 FROVA 58 Initiates Enrollment 58 multicenter Phase II 58 Plenaxis TM 58 teduglutide 58 alfa 2a 58 OvaRex R 58 Lenocta 58 Vascular Disrupting Agent 58 Revlimid lenalidomide 58 docetaxel Taxotere 58 Visudyne R 58 Angiox R 58 Gefitinib 58 Phase IIIb study 58 recurrent ovarian cancer 58 oncology indications 58 refractory metastatic colorectal cancer 58 Angiox 58 Ranolazine 58 Panzem ® 58 pradefovir 58 Virulizin R 58 AKT inhibitor 58 AAG geldanamycin analog 58 Drug Eluting Stent System 58 ZENPEP 58 HoFH 58 HuLuc# 58 intravenous acetaminophen 58 BR.# 58 Docetaxel 58 glioblastoma multiforme GBM 58 vandetanib 58 pralatrexate injection folate analogue 58 MDV# 58 Major Depressive Disorder MDD 58 SUMAVEL DosePro 58 Plicera 58 TG# [001] 58 modified glutathione analog 58 Fx #A 58 Valsartan 58 Orphan Drug Status 58 Ostabolin C 58 Emezine 58 Velcade bortezomib 58 Busulfex 58 Kuvan R 58 TRANSDUR ™ 58 PEG PAL 58 developing Bicifadine serotonin 58 Elotuzumab 58 Neulasta ® 58 Loramyc 58 cetrorelix 58 eltrombopag 58 IMiDs 58 ofatumumab 58 Elocalcitol 58 ZYBRESTAT 58 ATG Fresenius S 58 Nanobody 58 BEMA Buprenorphine 58 Neulasta R 58 edoxaban 58 JOULFERON 58 Behcet uveitis 58 Romiplostim 58 Li Fraumeni Syndrome 58 oral FTY# 58 BLA filing 58 Cardio Vascu Grow 58 refractory acute promyelocytic 58 oncological indications 58 dihydrochloride Tablets 58 metastatic bladder 58 Prestara TM 58 Genasense ® oblimersen 58 Folotyn 58 elvucitabine 58 Sycrest 58 Mycamine 58 ALN TTR# 58 diarrhea predominant irritable 58 TH# [003] 58 teriflunomide 58 Crofelemer budesonide foam